Home Patients Healthcare Professionals Contact Us


About AneuVysion


AneuVysion Prenatal Genetic Test

Prenatal Testing

How Does AneuVysion Work?

Indications For Use

Ordering the AneuVysion Test

Sample Images

U.S. Labs Offering AneuVysion Prenatal Test

International Labs Offering AneuVysion Prenatal Test

AneuVysion Patient Guide

FISH Overview


Prenatal Testing

Amniocentesis

Chorionic Villus Sampling (CVS)

Maternal Serum Screening

Karyotyping

High Risk Pregnancies

Pregnancy Ultrasound Screening


Genetic Disorders

Genetics

Down syndrome

Turner Syndrome

Klinefelter Syndrome

Trisomy


Glossary


Physician Guide


Insurance Codes


Laboratory Specifications

3 Stage Protocol

An Accurate and Reliable Test

Kit Components

Recommended Optical Sets


References

Rapid prenatal diagnosis of trisomy 21 in 5,049 consecutive uncultured amniotic fluid samples by fluorescence in situ hybridisation (FISH)

Prenatal diagnosis using interphase fluorescence in situ hybridization (FISH)

Rapid Prenatal Diagnosis of Aneuploidies in Uncultured Amniocytes by Fluorescence in situ Hybridization


Glossary


Bibliography

For In Vitro Diagnostic Use
The AneuVysion® Assay (CEP 18, X, Y-alpha satellite, LSI 13 and 21) Multi-color Probe Panel is intended to use CEP 18/X/Y probe to detect alpha satellite sequences in the centromere regions of chromosomes 18, X and Y and LSI 13/21 probe to detect the 13q14 region and the 21q22.13 to 21q22.2 region. The AneuVysion kit is indicated for identifying and enumerating chromosomes 13,18, 21, X and Y via fluorescence in situ hybridization (FISH) in metaphase cells and interphase nuclei obtained from amniotic fluid in subjects with presumed high risk pregnancies. It is not intended to be used as a stand alone assay for making clinical decisions. FISH results are intended to be used as an aid in the diagnosis of numerical abnormalities of chromosomes 13, 18, 21, X and/or Y in conjunction with other information currently used in prenatal diagnosis, consistent with professional standards of practice*. This device is intended for use only with amniocyte cells; it is not intended for and has not been validated for use with other test matrices. This FISH assay will not detect the presence of structural chromosome abnormalities that can also result in birth defects. This FISH assay will be performed in cytogenetic laboratories.

*American College of Medical Genetics (ACMG). Technical and clinical assessment of fluorescence in situ hybridization: an ACMG/ASHG position statement. I. Technical considerations. Genetics in Medicine (2000) 2 6:356-61.
Home | Patients | Healthcare Professionals | Contact Us
Doc ID: 30-650002
Last Modified: 3/31/2006
Revision: B
Vysis Inc.
3100 Woodcreek Drive
Downers Grove,IL60515-5400
USA

Phone: 800-553-7042 FAX: 630-271-7138 Email: vysis_help@vysis.com
Copyright Vysis Inc.© 2008 All rights reserved worldwide.